Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.01 billion. The enterprise value is $5.17 billion.
| Market Cap | 5.01B |
| Enterprise Value | 5.17B |
Important Dates
The last earnings date was Thursday, April 24, 2025, before market open.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | Dec 26, 2024 |
Share Statistics
Balchem has 32.62 million shares outstanding. The number of shares has increased by 0.81% in one year.
| Current Share Class | 32.62M |
| Shares Outstanding | 32.62M |
| Shares Change (YoY) | +0.81% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 90.22% |
| Float | 32.40M |
Valuation Ratios
The trailing PE ratio is 36.85 and the forward PE ratio is 29.75. Balchem's PEG ratio is 3.13.
| PE Ratio | 36.85 |
| Forward PE | 29.75 |
| PS Ratio | 5.16 |
| Forward PS | 4.84 |
| PB Ratio | 4.15 |
| P/TBV Ratio | 20.07 |
| P/FCF Ratio | 33.24 |
| P/OCF Ratio | 27.08 |
| PEG Ratio | 3.13 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.68, with an EV/FCF ratio of 34.29.
| EV / Earnings | 37.86 |
| EV / Sales | 5.36 |
| EV / EBITDA | 21.68 |
| EV / EBIT | 26.73 |
| EV / FCF | 34.29 |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.44 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 1.38 |
| Interest Coverage | 13.76 |
Financial Efficiency
Return on equity (ROE) is 11.94% and return on invested capital (ROIC) is 8.58%.
| Return on Equity (ROE) | 11.94% |
| Return on Assets (ROA) | 7.54% |
| Return on Invested Capital (ROIC) | 8.58% |
| Return on Capital Employed (ROCE) | 13.09% |
| Revenue Per Employee | $708,702 |
| Profits Per Employee | $100,325 |
| Employee Count | 1,361 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 4.87 |
Taxes
In the past 12 months, Balchem has paid $41.00 million in taxes.
| Income Tax | 41.00M |
| Effective Tax Rate | 23.09% |
Stock Price Statistics
The stock price has increased by +9.24% in the last 52 weeks. The beta is 0.75, so Balchem's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +9.24% |
| 50-Day Moving Average | 164.54 |
| 200-Day Moving Average | 168.75 |
| Relative Strength Index (RSI) | 39.24 |
| Average Volume (20 Days) | 216,961 |
Short Selling Information
The latest short interest is 519,220, so 1.59% of the outstanding shares have been sold short.
| Short Interest | 519,220 |
| Short Previous Month | 468,053 |
| Short % of Shares Out | 1.59% |
| Short % of Float | 1.60% |
| Short Ratio (days to cover) | 2.30 |
Income Statement
In the last 12 months, Balchem had revenue of $964.54 million and earned $136.54 million in profits. Earnings per share was $4.17.
| Revenue | 964.54M |
| Gross Profit | 342.86M |
| Operating Income | 193.42M |
| Pretax Income | 147.82M |
| Net Income | 136.54M |
| EBITDA | 238.45M |
| EBIT | 193.42M |
| Earnings Per Share (EPS) | $4.17 |
Balance Sheet
The company has $49.90 million in cash and $208.07 million in debt, giving a net cash position of -$158.17 million or -$4.85 per share.
| Cash & Cash Equivalents | 49.90M |
| Total Debt | 208.07M |
| Net Cash | -158.17M |
| Net Cash Per Share | -$4.85 |
| Equity (Book Value) | 1.21B |
| Book Value Per Share | 37.06 |
| Working Capital | 200.68M |
Cash Flow
In the last 12 months, operating cash flow was $185.07 million and capital expenditures -$34.31 million, giving a free cash flow of $150.76 million.
| Operating Cash Flow | 185.07M |
| Capital Expenditures | -34.31M |
| Free Cash Flow | 150.76M |
| FCF Per Share | $4.62 |
Margins
Gross margin is 35.55%, with operating and profit margins of 20.05% and 14.16%.
| Gross Margin | 35.55% |
| Operating Margin | 20.05% |
| Pretax Margin | 18.41% |
| Profit Margin | 14.16% |
| EBITDA Margin | 24.72% |
| EBIT Margin | 20.05% |
| FCF Margin | 15.63% |
Dividends & Yields
This stock pays an annual dividend of $0.87, which amounts to a dividend yield of 0.57%.
| Dividend Per Share | $0.87 |
| Dividend Yield | 0.57% |
| Dividend Growth (YoY) | 10.13% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 20.86% |
| Buyback Yield | -0.81% |
| Shareholder Yield | -0.24% |
| Earnings Yield | 2.72% |
| FCF Yield | 3.01% |
Analyst Forecast
The average price target for Balchem is $190.00, which is 23.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $190.00 |
| Price Target Difference | 23.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 9.88 and a Piotroski F-Score of 7.
| Altman Z-Score | 9.88 |
| Piotroski F-Score | 7 |